KLA [KLAC] vs Lam Research [LRCX] Detailed Stock Comparison
KLA
NASDAQ
Loading...
Lam Research
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: KLA wins in 9 metrics, Lam Research wins in 11 metrics, with 0 ties. Lam Research appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | KLA | Lam Research | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.24 | 23.80 | Lam Research |
| Price-to-Book Ratio | 24.99 | 12.70 | Lam Research |
| Debt-to-Equity Ratio | 125.40 | 45.47 | Lam Research |
| PEG Ratio | 27.07 | 23.13 | Lam Research |
| EV/EBITDA | 21.93 | 19.06 | Lam Research |
| Profit Margin (TTM) | 33.41% | 29.07% | KLA |
| Operating Margin (TTM) | 42.65% | 33.67% | KLA |
| EBITDA Margin (TTM) | 42.65% | 33.67% | KLA |
| Return on Equity | 100.78% | 58.24% | KLA |
| Return on Assets (TTM) | 19.90% | 18.40% | KLA |
| Free Cash Flow (TTM) | $3.03B | $4.26B | Lam Research |
| Dividend Yield | 0.77% | 1.00% | Lam Research |
| 1-Year Return | 22.50% | 25.94% | Lam Research |
| Price-to-Sales Ratio (TTM) | 9.66 | 6.80 | Lam Research |
| Enterprise Value | $118.67B | $119.82B | Lam Research |
| EV/Revenue Ratio | 9.76 | 6.50 | Lam Research |
| Gross Profit Margin (TTM) | 61.62% | 49.02% | KLA |
| Revenue per Share (TTM) | $91 | $14 | KLA |
| Earnings per Share (Diluted) | $30.38 | $4.15 | KLA |
| Beta (Stock Volatility) | 1.43 | 1.66 | KLA |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
KLA vs Lam Research Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| KLA | 0.30% | 3.18% | -0.48% | 30.07% | 21.74% | 43.70% |
| Lam Research | 2.62% | 5.58% | 1.92% | 35.85% | 21.52% | 40.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| KLA | 22.50% | 139.98% | 332.51% | 1,686.72% | 3,043.64% | 1,794.00% |
| Lam Research | 25.94% | 96.20% | 172.35% | 1,299.59% | 2,598.94% | 3,445.30% |
Performance & Financial Health Analysis: KLA vs Lam Research
| Metric | KLAC | LRCX |
|---|---|---|
| Market Information | ||
| Market Cap | $117.47B | $125.29B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,121,840 | 11,632,538 |
| 90 Day Avg. Volume | 967,647 | 10,172,263 |
| Last Close | $914.80 | $101.75 |
| 52 Week Range | $551.33 - $945.87 | $56.32 - $102.59 |
| % from 52W High | -3.28% | -0.82% |
| All-Time High | $945.87 (Jul 18, 2025) | $113.00 (Jul 08, 2024) |
| % from All-Time High | -3.28% | -9.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.24% | 0.34% |
| Quarterly Earnings Growth | 0.44% | 0.69% |
| Financial Health | ||
| Profit Margin (TTM) | 0.33% | 0.29% |
| Operating Margin (TTM) | 0.43% | 0.34% |
| Return on Equity (TTM) | 1.01% | 0.58% |
| Debt to Equity (MRQ) | 125.40 | 45.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.54 | $7.77 |
| Cash per Share (MRQ) | $34.04 | $5.04 |
| Operating Cash Flow (TTM) | $3.02B | $6.17B |
| Levered Free Cash Flow (TTM) | $2.76B | $4.61B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.77% | 1.00% |
| Last 12-Month Dividend | $6.75 | $0.92 |
Valuation & Enterprise Metrics Analysis: KLA vs Lam Research
| Metric | KLAC | LRCX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.24 | 23.80 |
| Forward P/E | 27.07 | 23.13 |
| PEG Ratio | 27.07 | 23.13 |
| Price to Sales (TTM) | 9.66 | 6.80 |
| Price to Book (MRQ) | 24.99 | 12.70 |
| Market Capitalization | ||
| Market Capitalization | $117.47B | $125.29B |
| Enterprise Value | $118.67B | $119.82B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.76 | 6.50 |
| Enterprise to EBITDA | 21.93 | 19.06 |
| Risk & Other Metrics | ||
| Beta | 1.43 | 1.66 |
| Book Value per Share (MRQ) | $35.54 | $7.77 |
Financial Statements Comparison: KLA vs Lam Research
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KLAC | LRCX |
|---|---|---|
| Revenue/Sales | $3.06B | $4.72B |
| Cost of Goods Sold | $1.18B | $2.41B |
| Gross Profit | $1.89B | $2.31B |
| Research & Development | $338.04M | $525.90M |
| Operating Income (EBIT) | $1.30B | $1.56B |
| EBITDA | $1.43B | $1.68B |
| Pre-Tax Income | $1.26B | $1.54B |
| Income Tax | $176.02M | $206.06M |
| Net Income (Profit) | $1.09B | $1.33B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KLAC | LRCX |
|---|---|---|
| Cash & Equivalents | $1.86B | $5.45B |
| Total Current Assets | $9.95B | $13.46B |
| Total Current Liabilities | $3.91B | $5.49B |
| Long-Term Debt | $6.05B | $3.73B |
| Total Shareholders Equity | $4.00B | $9.51B |
| Retained Earnings | $1.65B | $27.56B |
| Property, Plant & Equipment | $268.41M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KLAC | LRCX |
|---|---|---|
| Operating Cash Flow | $1.07B | $1.50B |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $987.17M | $1.02B |
| Debt Repayment | $0 | $-504.04M |
| Common Stock Repurchase | $-506.75M | $-435.08M |
Short Interest & Institutional Ownership Analysis
| Metric | KLAC | LRCX |
|---|---|---|
| Shares Short | 3.13M | 30.18M |
| Short Ratio | 3.04 | 2.99 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 1,121,840 | 11,632,538 |
| Average Daily Volume (90 Day) | 967,647 | 10,172,263 |
| Shares Outstanding | 134.43M | 1.30B |
| Float Shares | 131.74M | 1.26B |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.91% | 0.88% |
Dividend Analysis & Yield Comparison: KLA vs Lam Research
| Metric | KLAC | LRCX |
|---|---|---|
| Last 12-Month Dividend | $6.75 | $0.92 |
| Last 12-Month Dividend Yield | 0.77% | 1.00% |
| 3-Year Avg Annual Dividend | $5.87 | $0.80 |
| 3-Year Avg Dividend Yield | 0.27% | 0.30% |
| 3-Year Total Dividends | $17.60 | $2.40 |
| Ex-Dividend Date | May 19, 2025 | Jun 18, 2025 |